OrdoƱez, Caesar E.
Karonis, Nicholas T.
Duffin, Kirk L.
Winans, John R.
DeJongh, Ethan A.
DeJongh, Don F.
Coutrakon, George
Myers, Nicole F.
Pankuch, Mark
Welsh, James S. http://orcid.org/0000-0002-3255-6412
Funding for this research was provided by:
National Cancer Institute of the National Institutes of Health (R44CA203499)
US Department of the Army (W81XWH-10-1-0170)
the US Department of Energy (DE-SC0005135)
Article History
Received: 12 February 2019
Accepted: 9 May 2019
First Online: 25 May 2019
Compliance with ethical standards
:
: The National Cancer Institute of the National Institutes of Health contract number R44CA203499, the US Department of the Army contract number W81XWH-10-1-0170, and the US Department of Energy contract number DE-SC0005135 sponsored this work. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office for contract number W81XWH-10-1-0170. The content in this article does not necessarily reflect the position or policy of the Government, and no official endorsement should be inferred.
: The authors have intellectual property rights to the innovations described in this paper. James S. Welsh has served as a medical advisor to ProTom International. Don F. Dejongh is a co-owner of ProtonVDA Inc.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Statement of informed consent was not applicable since the manuscript does not contain any patient data.